Page 6 - Rekomendasi Tentang Pengawasan Pemanfaatan Plasma Konvalesen dan Imunoglobulin Konsentrat dalam Terapi COVID-19 dan Petunjuk Teknis Penjaminan Mutu Pengolahan Plasma Konvalesen COVID-19
P. 6

Daftar Isi




            Kata Pengantar .......................................................................................... i
            Tim Penyusun ........................................................................................... iii

            Daftar Isi ................................................................................................... iv
            I.   LATAR BELAKANG ............................................................................. 1

            II.   TUJUAN ............................................................................................ 2
            III.  RUANG LINGKUP ............................................................................... 2
            IV.  PRINSIP PENGGUNAAN PLASMA KONVALESEN DAN
                 IMUNOGLOBULIN KONSENTRAT COVID-19 DI INDONESIA ................. 3
                 4.1.  Skema Penggunaan Plasma Konvalesen dan
                     Imunoglobulin Konsentrat ......................................................... 3
                 4.2.  Kriteria Pasien ........................................................................... 4

                 4.3.  Kelayakan Donor ....................................................................... 4

            V.   JAMINAN MUTU PENGGUNAAN PLASMA KONVALESEN DAN
                 IMUNOGLOBULIN KONSENTRAT........................................................ 5

                 5.1.  Persyaratan Produk ................................................................... 5
                 5.2.  Fasilitas Pengambilan dan Pengolahan Plasma Konvalesen
                     COVID-19 .................................................................................. 6
                 5.3.  Pencatatan ............................................................................... 6

                 5.4.  Pelabelan .................................................................................. 6




                                                                        iv
   1   2   3   4   5   6   7   8   9   10   11